ARTICLE | Company News
C Sixty, Merck deal
October 20, 2003 7:00 AM UTC
Under an exclusive research and supply deal, MRK will seek to develop compounds in two undisclosed therapeutic areas based on C Sixty's fullerene antioxidants. MRK also obtained an option for a commer...